| Contact Us Toll Free |
| Global |
1 866 629 7100 |
| Local |
402 697 6500 |
| E-mail |
General Inquires |
|
|
Qualia utilizes a multi-faceted study recruitment strategy, managing the entire process internally to guarantee quality. We have a proven track record of reaching recruitment targets effectively and on budget.
Our client-focused environment ensures timely and reliable recruiting service. We have a proven system for evaluating study recruitment needs and can offer clients realistic expectations regarding their specific needs. Our flexible and proactive approach guarantees that prompt and consistent service is always a top priority.
Early Phase
In Omaha we maintain an active and growing database. Recruitment volume grew by nearly 30% each month during 2007, and Qualia’s recruitment efforts position us to sustain a high rate of growth. We have access to over 100,000 college students and have cultivated relationships within the medical community, allowing Qualia to target patient populations with speed and confidence. Our Physician Network allows access to many populations that cannot be obtained in other regions.
Our process for attracting quality participants relies on a combination of outreach and advertising, and we develop a customized strategy for each study. Prospective subjects are reached through a combination of radio, newspapers, television, direct mail, online, and billboards. Qualia maintains a prominent position in the area through outreach and community events. We operate an on-site call center, providing immediate and accurate information to prospective participants and clients.
Late Phase
The Toronto clinic has been active in patient clinical trials since 2004 and has developed a large database of patients along with a network of referring physicians and specialists. Our Kiev facility is staffed with an experience local team and maintains a unique database of investigational sites in Ukraine and Europe. We have developed extensive professional and personal relationships with highly qualified investigational teams experienced in ICH-GCP compliant studies across various therapeutic areas. Participants are highly motivated and we offer an ideal environment for recruiting specialty patient populations.
|
Subject Recruitment
We recruit from the pool of over 1 million residents in the Omaha and surrounding areas. Clients can have access to a large and ethnically diverse subject pool. This population allows Qualia to recruit subjects rapidly for studies. Prospective subjects are reached through our regular advertisements in radio, newspapers, television, website, billboards, flyers, outreach and community events. We utilize Study Manager CTMS database, which is a comprehensive subject database system to track subject recruitment, screening and participation, including demographic and medical information.
Subject Screening
All subject-screening activities are conducted in a separate screening area within our facility. Prospective subjects are administered informed consent, complete medical history, vital signs, urine and blood collection and physical examination, which are conducted by medically trained personnel and supervised by the PI/Medical Director. Prospective subjects undergo an informed consent procedure, during which they are informed of their rights and obligations, potential side effects and other study details. We are directly linked to a central clinical laboratory which provides a quick turnaround of test results for blood chemistry, hematology, urinalysis for medical screening or other study specific requirements.
Subject Safety
All study protocols are reviewed by the PI, clinic’s Executive Director, Director of Recruiting and the clinical research coordinator to guarantee subject safety and strict adherence to standards. Prior to study start, an Institutional Review Board (IRB) reviews the study protocol and consent form that outlines the study and provides explicit details of any known potential side effects. The IRB is a review body put in place solely for the protection of the rights and safety of research subjects. All studies are designed and conducted in accordance to strict guidelines regulated under the Food & Drug Administration (FDA) in US and the EMEA in Europe.
|
|